CClinicalTrials.gg
CompletedNCT02406638Updated Apr 2, 2015

Pelvic Floor 3D USG Three Years After Mid-urethral Slings ( TVT-R, TVT-O, TVT-S)

An observational study in Urinary Incontinence and Postoperative Period, sponsored by Federal University of São Paulo. Completed at 1 site in Brazil. Open to female participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2015-04-02.

Sponsored by Federal University of São Paulo · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
158
Ages
18 Years to 90 Years
Sex
Female
01

Study summary

Compare through 3D USG the tape spatial orientation, in three different techniques of insertion of mid-urethral synthetic sling, correlating USG findings to postoperative results in an average of three years follow-up.

Methods: This is a transversal study of a cohort women surgically treated for stress urinary incontinence by retropubic sling (TVT-R), transobturator sling (TVT-O) or single-incision sling (TVT-S). The clinical and USG evaluation were performed at the same medical visit, from April 2013 to June 2014, .

Read the detailed description

Introduction: The three dimensional ultrasonography (3D USG) provides a clear spatial orientation of polypropylene tape and can help clarify the pathogenesis of bladder dysfunction after a TVT procedure. Thus, the USG in urogynecology postoperative has shown an increasing role in monitoring surgically treated patients and specially in complications such as urinary retention and urinary disorders.

Objective: Compare through 3D USG the tape spatial orientation, in three different techniques of insertion of mid-urethral synthetic sling, correlating USG findings to postoperative results in an average of three years follow-up.

Methods: This is a transversal study of a cohort of women surgically treated for stress urinary incontinence by retropubic sling (TVT-R), transobturator sling (TVT-O) or single-incision sling (TVT-S). The surgeries occurred from May 2009 to December 2011. Were eligible for the study 158 patients. The clinical and USG evaluation were performed at the same medical visit, from April 2013 to June 2014, after local ethics committee approval and signature of informed consent. The objective cure rates were evaluated by negative pad-test and stress test. The subjective cure rate and urgency symptoms were accessed by questionnaires. The subjective cure was defined as absence of reports of stress urinary leakage.

The USG evaluation was performed using General Electric Voluson 730 expert systems with 8 - 4 Mhz volume transducers with an 85-degree acquisition angle. The exams were performed with patient in supine position with hip flexed and using slightly abduced, after voiding. The US transducer was placed on the perineum in the midsagittal position and volumes were obtained at rest, at maximum Valsalva, and perineal contraction. Moved mode rendering for OMNINI View plan as previous described.The volumes datasets were analyzed offline by of the authors. They were blinded and the average values were considered.

The urethral length and the location of the sling, measured by the distance between bladder neck and the tape (CF), were assessed in midsagittal plane. The tape angle in relation to the urethra were assessed in OMINI VIEW plan.

Statistical analysis was performed using student t, ANOVA and Tukey-test. P value of \<0.05 was considered statistically significant.

02

Conditions studied

  • Urinary Incontinence
  • Postoperative Period

Keywords

  • 3D Pelvic floor USG
  • Mid-Urethral Sling
  • TVT
  • TVT-O
  • TVT-S
03

In context

Urinary Incontinence

1,363 studies on the registry are indexed under Urinary Incontinence; 228 are open to participants now.

This study's enrollment of 158 is above the median of 120 across 305 observational studies indexed under Urinary Incontinence.

Browse Urinary Incontinence studies →

Lead sponsor

Federal University of São Paulo is the lead sponsor of 427 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Women who underwent stress urinary incontinence surgery with synthetic midurethral sling, by different approaches ( TVT, TVT-O and TVT-Secur) in a period of 2 to 4 years before clinical and 3D USG evaluation

Inclusion criteria

  • Women who underwent surgical treatment for stress urinary incontinence using TVT, TVT-O and TVT-Secur, in a period of 2 to 4 years before the USG evaluation
  • Informed consent signed

Exclusion criteria

Exclusion Criteria:

  • Patients who underwent to more than one surgery for urinary incontinence using polypropylene tape
  • Ultrasound images that would not allow adequate visualization of the tape
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
158 participants (actual)
Patient registry
No

Groups and cohorts

  • TVT Group

    Women who underwent to stress urinary incontinence surgery using Gynecare TVT 3 years before clinical and 3D pelvic floor ultrasound evaluation.

    Other: 3D pelvic floor ultrasound

  • TVT-O Group

    Women who underwent to stress urinary incontinence surgery using Gynecare TVT Obturator System, inside-out approach, 3 years before clinical and 3D pelvic floor ultrasound evaluation.

    Other: 3D pelvic floor ultrasound

  • TVT-S Group

    Women who underwent to stress urinary incontinence surgery using GynecareTVT-Secur System, in "U" approach, 3 years before clinical and 3D pelvic floor ultrasound evaluation.

    Other: 3D pelvic floor ultrasound

Interventions

  • Other3D pelvic floor ultrasound

    Pelvic Floor 3D Ultrasound Clinical evaluation with pad-test, stress test and questionnaires of symptoms and quality of life

06

What researchers measure

Primary outcomes

  1. Determination of the tape spatial position ( angle between tape arms surrounding urethra measured in grades) in three different techniques of insertion of midurethral synthetic sling (TVT, TVT-O, TVT-S)

    Measured of the angle between tape arms surrounding urethra (in grades) in the three different suburethral tapes measured by 3D USG at rest Valsalva and pelvic floor contraction

    Time frame: evaluation will occur in 1 day, 3 years after surgery

Secondary outcomes

  1. Correlation between the suburethral tape spatial positon and objective cure rate

    Correlation between the tape spatial position measured by 3D USG and objective cure rates, accessed by stress test and pad-test

    Time frame: evaluation will occur in 1 day, 3 years after surgery

  2. Correlation between the suburethral tape spatial positon and subjective cure rate

    Correlation between the tape spatial position measured by 3D USG and subjective cure, accessed by scale of symptoms of King's Health Questionnaire

    Time frame: evaluation will occur in 1 day, 3 years after surgery

  3. Correlation between the suburethral tape spatial positon and urge-symptoms

    Correlation between the tape spatial position measured by 3D USG and urge-symptoms, accessed by scale of symptoms of King's Health Questionnaire

    Time frame: evaluation will occur in 1 day, 3 years after surgery

  4. Determination of the tape position, distance between the tape and vesical neck (measured in mm) in three different techniques of insertion of midurethral synthetic sling (TVT, TVT-O, TVT-S)

    Measured of the distance between the tape and vesical neck, in mm, of the three different suburethral tapes measured by 3D USG at rest Valsalva and pelvic floor contraction.

    Time frame: evaluation will occur in 1 day, 3 years after surgery

  5. Determination of the tape position, relation between urethral length and distance between tape and vesical neck (measured in mm) in three different techniques of insertion of midurethral synthetic sling (TVT, TVT-O, TVT-S)

    Relation between the measured of urethral length (mm) and the distance between the tape and vesical neck( in mm), measured by 3D USG at rest Valsalva and pelvic floor contraction of the three different suburethral tapes, in order to determine if they remain in the midurethra.

    Time frame: evaluation will occur in 1 day, 3 years after surgery

07

Study locations

1 site
  • Federal University of Sao Paulo - Unifesp
    São Paulo, SP 0-4023- 062, Brazil
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 2, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02406638
Lead sponsor
Federal University of São Paulo
Responsible party
Ana Maria Homem de Mello Bianchi (PhD, Federal University of São Paulo) — Principal investigator
First posted
Apr 2, 2015
Start date
Apr 2013
Primary completion
Jun 2014
Completion
Mar 2015
Last update
Apr 2, 2015

Study contacts

Claudinei A Rodrigues, MD
principal investigator · Federal University of São Paulo
Zsuzsanna IK Jármy-di-Bella, PhD
study chair · Federal University of São Paulo
Ana Maria HM Bianchi-Ferraro, PhD
study director · Federal University of São Paulo

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion